Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


ASTRAZENECA R&D

ASTRAZENECA R&D Patent applications
Patent application numberTitlePublished
20110178064SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL - In one aspect, the present invention relates to compounds of Formula (I): to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to method for their preparation.07-21-2011
20110105449DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES - The invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.05-05-2011
20100280048Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase - The invention provides certain novel 6-heteroaryl-5-methyl-3-oxo-4-[3(trifluoromethyl)phenyl]-3,4-dihydropyrazine-2-carboxamide derivatives and pharmaceutically acceptable salts thereof and particular Forms thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase.11-04-2010
20100261690NOVEL COMBINATIONS - The invention provides a pharmaceutical product comprising, in combination, (1) a named glucocorticosteroid receptor agonist and (2) a β10-14-2010
20100249112COMBINATION OF CHK AND PARP INHIBITORS FOR THE TREATMENT OF CANCERS - A combination, comprising a checkpoint kinase (CHK) inhibitor, or a pharmaceutically acceptable salt thereof, and a poly (ADP-ribose)polymerase (PARP) inhibitor, or a pharmaceutically acceptable salt thereof is described.09-30-2010
20100210648PYRAZOLYLAMINOPYRIMIDINE DERIVATIVES USEFUL AS TYROSINE KINASE INHIBITORS - This invention relates to novel compounds having the formula (I):08-19-2010
20100152219PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES - Compounds of formula (I): and their use in the inhibition of Trk activity are described.06-17-2010

Patent applications by ASTRAZENECA R&D